" class="no-js "lang="en-US"> Nadhim Zahawi Archives - Medtech Alert
Wednesday, September 27, 2023

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

England to Return to Plan A Following the Success of the Booster Programme

The government has today announced that England will fully return to Plan A on Thursday […]

Testing Measures to Ensure Young People Return to Classrooms

All secondary schools have been asked to provide one on-site test for pupils ahead of […]

Nightlife Industry Joins Covid-19 Vaccine Push for Young People

Leading figures of the nightlife industry – including venues Ministry of Sound and Heaven – […]

Almost 100% of People Have Antibodies After Second Vaccine

Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, […]

Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive

Collaboration comes as all adults aged 18 and over invited to get a jab Filters […]

More than 30 Million People Vaccinated with Second Dose

More than 30 million people in the UK have been vaccinated with a second dose […]

60 Million Doses of Covid-19 Vaccine Administered in UK

Around 72% of UK adults have received a first dose of a COVID-19 vaccine, the […]

World-first Covid-19 Vaccine Booster Study Launches in UK

Thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial launching […]

Next Phase of Vaccine Roll-Out

The UK is moving into the next phase of the COVID-19 vaccine programme as the […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more